Frank Binder
Founder at Lloyd Yachts SAM
Network origin in Frank Binder first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
51
| Public Company | Pharmaceuticals: Major | 51 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Frank Binder via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chairman Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member | |
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Verband der Chemischen Industrie eV
 Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal President Human Resources Officer Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Consultant / Advisor | |
| University of Giessen | College/University | Corporate Officer/Principal Masters Business Admin | |
Merck Millipore Corp.
 Merck Millipore Corp. Miscellaneous Commercial ServicesCommercial Services Merck Millipore Corp. provides biotechnological research and development services. It offers for antibodies, organic compounds, proteins and enzymes complexes, inhibitors, capsule filter, cartridge filters, kits and assays, housings, inorganic compounds, amino acid derivatives, filter discs and membranes, cell lines, test methods and kits, cell culture media and reagents, water purification systems, and filters and holders and accessories for health care. The company was founded in 1954 and is headquartered in Darmstadt, Germany. | Miscellaneous Commercial Services | Chief Executive Officer Human Resources Officer | |
| ANTERIS TECHNOLOGIES LTD | Medical Specialties | Chief Executive Officer Chief Operating Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BÂLOISE HOLDING AG | Multi-Line Insurance | Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
Merck Santé SASU
 Merck Santé SASU Pharmaceuticals: MajorHealth Technology Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Executive Officer President | |
| Procom RX | Chairman Chief Executive Officer | ||
| University of Geneva | College/University | Undergraduate Degree Doctorate Degree | |
| BASF SE | Electrical Products | Corporate Officer/Principal Corporate Officer/Principal | |
| PT MERCK TBK | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Operating Officer President | |
| Ashridge Business School | College/University | Masters Business Admin Masters Business Admin | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal Chairman | |
Aicuris Anti-Infective Cures AG
 Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chairman Founder | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree | |
| Technische Universität München | College/University | Doctorate Degree Corporate Officer/Principal | |
| Wageningen University | College/University | Graduate Degree | |
K2View Ltd.
 K2View Ltd. Packaged SoftwareTechnology Services K2View Ltd. is a software company engaging in the provision of data-as-service. Its products include K2View Fabric, K2View ADI, and K2View TDM. The company was founded by Rafi Cohen and Achi Rotem in 2009 and is headquartered in Yokneam, Israel. | Packaged Software | Director/Board Member | |
icometrix NV
 icometrix NV Packaged SoftwareTechnology Services icometrix NV provides software as a service for medical image analysis. It engages in the advanced quantitative image processing of human as well as animal data sets, including multi-modal and multi-subject image registration (PET/CT, PET/MR, and CT/MR), volumetric measurements, group analysis of diffusion weighted and tensor images, functional MRI, perfusion MRI, MR spectroscopy, atrophy measurement, automatic and semi-automatic tissue segmentation. The company was founded by Dirk Loeckx, Wim Van Hecke, Paul Suetens, Stefan Sunaert, Paul M. Parizel, Frederik Maes and Jan Sijbers in 2011 and is headquartered in Leuven, Belgium. | Packaged Software | Director/Board Member | |
Forestay Capital SA
 Forestay Capital SA Investment ManagersFinance Forestay Capital SA (Forestay Capital) is a venture capital subsidiary of Waypoint Capital Holdings (Jersey) Ltd founded in 2017. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Investor | |
WayPoint Capital LLC
 WayPoint Capital LLC Investment ManagersFinance WayPoint Capital LLC provides professional, scientific and technical services. The company was founded in 2011 and is headquartered in Spokane, WA. | Investment Managers | Chief Tech/Sci/R&D Officer | |
Affidea Group BV
 Affidea Group BV Medical/Nursing ServicesHealth Services Affidea Group BV provides diagnostic and renal care services. It is a medical service provider that offers diagnostic investigations, renal care, clinical laboratories, cancer treatment, and teleradiology services. The firm also operates centers for dialysis, diagnostic, and cancer treatment purposes. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
| LAVA THERAPEUTICS N.V. | Biotechnology | Corporate Officer/Principal | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Wellington Management Co. LLP (Private Equity)
 Wellington Management Co. LLP (Private Equity) Investment ManagersFinance Wellington Management Co. LLP (Private Equity) (Wellington Management) is a private equity firm, a subsidiary of Wellington Management Co. LLP founded in 1933. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| CHECKMATE PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin | |
| University of Leiden | College/University | Doctorate Degree | |
Altmann-Analytik GmbH & Co. KG
 Altmann-Analytik GmbH & Co. KG Medical SpecialtiesHealth Technology Altmann-Analytik GmbH & Co. KG is a laboratory equipment supplier based in Germany. The German company offers over 300,000 products online and prides itself on being a competent and independent laboratory specialist. Tobias Thelen has been the CEO of the private company since 2010. | Medical Specialties | Chief Executive Officer | |
Fast Forward Pharmaceuticals BV
 Fast Forward Pharmaceuticals BV Medical SpecialtiesHealth Technology Fast Forward Pharmaceuticals BV develops novel disease-modifying therapeutics for the treatment of inflammatory and autoimmune diseases. It is developing an anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The company was founded by Louis Boon in October 2010 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Chief Operating Officer | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Other | Founder |
Statistics
International
| United States | 16 |
| Germany | 12 |
| Switzerland | 8 |
| Netherlands | 8 |
| United Kingdom | 4 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 5 |
| Technology Services | 4 |
Operational
| Director/Board Member | 169 |
| Corporate Officer/Principal | 123 |
| Chief Executive Officer | 51 |
| Chairman | 47 |
| Undergraduate Degree | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Elmar Schnee | 31 |
| Wolfgang Heinz Büchele | 28 |
| Nilesh Kumar | 26 |
| Stefan Oschmann | 23 |
| Simon Sturge | 20 |
| Arend Oetker | 18 |
| Paris Panayiotopoulos | 18 |
| Udit Batra | 16 |
| Gregor Schulz | 16 |
| Jean-Paul Mangeolle | 16 |
| Helga Rübsamen-Schaeff | 16 |
| Rolf Krebs | 15 |
| Matthias Zachert | 14 |
| Allene Diaz | 14 |
| Bradley David Simpson | 12 |
- Stock Market
- Insiders
- Frank Binder
- Company connections
